<DOC>
	<DOC>NCT03016325</DOC>
	<brief_summary>A Study to Evaluate Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of HNO Donor in Hospitalized Patients with Heart Failure and Impaired Systolic Function</brief_summary>
	<brief_title>Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>For more information regarding BristolMyers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Actively being hospitalized for acute decompensated heart failure At least 1 administration of IV diuretic for the current episode Be randomized within 18 hours of first dose of IV diuretic for current episode Have shortness of breath at rest or with minimal exertion after administration of 1 dose of IV diuretic Have history of heart failure and a left ventricular ejection fraction (LVEF) â‰¤ 40% Systolic blood pressure &lt;105mm Hg or &gt;160mm Hg or heart rate &lt;50 or &gt;130 bpm Have an active infection requiring IV antimicrobial treatment Severe lung disease that may interfere with assessments (e.g., severe chronic obstructive pulmonary disease, active asthma or acute pneumonia) Be hospitalized with acute coronary syndrome, coronary revascularization or acute myocardial infarction during the previous 90 days prior to screening Have a history of a cerebral vascular accident (CVA or stroke) or of a transient ischemic attack (TIA) during the previous 90 days prior to screening Other protocol defined inclusion/exclusion criteria could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>